Apellis Post Hoc Analysis Confirms Long-Term Benefit of SYFOVRE for Geographic Atrophy
Apellis Post Hoc Analysis Confirms Long-Term Benefit of SYFOVRE for Geographic Atrophy Maham Fatima Sun, November 30, 2025 at 1:26 PM GMT+8 2 min read In this article: APLS -1.34% Apellis Pharmaceutic...